PVI
TXG icon

Pura Vida Investments’s 10x Genomics TXG Stock Holding History

Pura Vida Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-38,005
Closed -$1.43M – 69
2024
Q1 		$1.43M Buy
+38,005
New +$1.67M 0.24% 41
2022
Q2 		– Sell
-22,257
Closed -$1.15M – 277
2022
Q1 		$1.69M Sell
22,257
-39,700
-64% -$3.47M 0.05% 168
2021
Q4 		$9.23M Sell
61,957
-1,704
-3% -$261K 0.33% 77
2021
Q3 		$9.27M Sell
63,661
-976
-2% -$168K 0.28% 92
2021
Q2 		$12.7M Sell
64,637
-6,067
-9% -$1.1M 0.39% 59
2021
Q1 		$12.8M Buy
70,704
+28,204
+66% +$4.87M 0.36% 60
2020
Q4 		$6.02M Sell
42,500
-32,220
-43% -$4.68M 0.22% 96
2020
Q3 		$9.32M Buy
74,720
+30,800
+70% +$3.23M 0.48% 43
2020
Q2 		$3.92M Sell
43,920
-10,700
-20% -$833K 0.38% 64
2020
Q1 		$3.4M Sell
54,620
-32,720
-37% -$2.55M 0.4% 54
2019
Q4 		$6.66M Sell
87,340
-2,660
-3% -$160K 0.59% 49
2019
Q3 		$4.54M Buy
+90,000
New +$4.98M 0.77% 44

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Pura Vida Investments's TXG Position: Q2 2024 in Review

Pura Vida Investments sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 38,005 shares — an estimated $1.43M sold.

Pura Vida Investments first reported a position in TXG in Q3 2019 and held it in 12 quarters. The position peaked at $12.8M in Q1 2021. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • Pura Vida Investments reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • Pura Vida Investments sold 38,005 10x Genomics shares in Q2 2024, an estimated $1.43M.
  • Pura Vida Investments first reported a position in 10x Genomics in Q3 2019 and held it in 12 quarters.
  • Pura Vida Investments's 10x Genomics position peaked at $12.8M in Q1 2021.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.